Growth hormone in the ageing male;Wachstumshormon beim älteren mann

Wiener Medizinische Wochenschrift

Volumn 151, Issue 18-20, 2001, Pages 426-429

  Riedl, Michaela ^a   Kotzmann, H ^a   Luger, Anton ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ageing; Growth hormone; Growth hormone deficiency; Growth hormone therapy

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

AGING; ARTICLE; BONE MINERAL; BREAST CARCINOMA; CANCER RISK; COLON CARCINOMA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEALTH STATUS; HUMAN; INSULIN SENSITIVITY; LUNG CARCINOMA; MUSCLE MASS; PATIENT MONITORING; PROSTATE CARCINOMA; RISK FACTOR; SKIN ATROPHY; TISSUE DISTRIBUTION;

AGING; BODY CONSTITUTION; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN-LIKE GROWTH FACTOR I; MALE; NEOPLASMS; PITUITARY-ADRENAL SYSTEM; RISK FACTORS;

EID: 0035738803     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Growth hormone binding proteins in plasma
2. Insulin-like growth factor (IGF-1) binding proteins: The role of serum IGFBPs in regulating IGF availability
3. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study
4. Stimulation of the growth hormone (GH)-insulin-like growth factor 1 axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects
5. Human growth hormone and human ageing
6. Clinical aspects of growth hormone deficiency in adults
7. Optimizing growth hormone replacement therapy by dose titration in hipopituitary adults
8. Variability in growth hormone stimulation tests
9. New approach to the diagnosis of growth hormone deficiency in adults
10. Insulin-like growth factor-1 and binding protein 3 and risk of cancer
11. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
12. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency
13. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer
14. Healthcare consumption decreases in parallel with improvements in quality of life during growth hormone replacement therapy in hypopituitary adults with GH deficiency
15. Thirty second sampling of plasma growth hormone (GH) in man: Correlation with sleep stages
16. Insulin-like growth factor 1 and the development of colorectal neoplasia in acromegaly
17. Beneficial effect of growth hormone treatment in GH-deficient adults
18. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
19. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency
20. Decreased peripheral insulin sensitivity in acromegalic patients
21. Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion
22. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF binding protein-3
23. Effects of short term administration of recombinant human growth hormone to elderly people
24. Insulin-like growth factor-1 stimulates c-fos and c-jun transcription in PC12 cells
25. Growth hormone replacement in healthy older men improves body composition but not functional ability
26. Responses of plasma adrenocorticotropin, Kortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy ageing men
27. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
28. Reduced thirst after water deprivation in healthy elderly men
29. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy
30. Premature mortality due to cardiovascular disease in hypopituitarism
31. Effects of human growth hormone in men over 60 years old
32. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescent assay
33. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men
34. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old
35. Safety of growth hormone replacement in adults
36. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk